Edison-based Pharmaceutical Formulations (OTC: PHFR) on Tuesday announced measures directed toward a recapitalization that would convert a significant portion of its current debt to equity. In a ...
BEIJING, Jan. 20, 2026 /PRNewswire/ -- "The recommendations for the 15th Five-Year Plan are the blueprint for China's economic and social development over the next five years and will unlock a growing ...
Apeiron Biologics is preparing to study an inhaled formulation of its ACE2 receptor decoy APN01. The clinical trial will test whether switching from intravenous to inhaled delivery can expand the ...
Exciting new human and animal studies designed to enhance business opportunities KELOWNA, BC / ACCESS Newswire / March 4, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX), (the "Company" or "Lexaria"), a ...
WATERTOWN, Mass., Oct. 04, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results